DJIA 17,203.96 12.59 0.07%
NASDAQ 4,621.89 -16.10 -0.35%
S&P 500 1,993.54 -8.62 -0.43%
market minute promo

6.10 0.04 (0.66%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

PGNX $6.10 0.66%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $6.05
Previous Close $6.06
Daily Range $6.00 - $6.17
52-Week Range $3.10 - $7.84
Market Cap $424.3M
P/E Ratio 55.09
Dividend (Yield) $0.00 (0.0%)
Volume 240,894
Average Daily Volume 1,022,813
Current FY EPS $0.02

Sector

Healthcare

Industry

Drugs

Progenics Pharmaceuticals, Inc. (PGNX) Description

A biopharmaceutical company focusing on the development and commercialization of innovative therapeutic products to treat the unmet medical needs of patients with debilitating conditions and life-threatening diseases. Website: http://www.progenics.com/

News & Commentary

This Week in Biotech: AbbVie's Five-Leaf Clover and Exelixis' Excellent Results

A long-awaited mega-merger is announced, Exelixis reminds Wall Street that its pipeline is more than a single compound, and Amgen shows flashes of what's coming down its pipeline.

Actavis' Q4 Earnings to Beat Expectations, Growth Continues - Analyst Blog

Actavis' Appeal Case for Namenda Gets Accelerated Hearing - Analyst Blog

Actavis' Appeal Case for Namenda Gets Accelerated Hearing - Analyst Blog

KaloBios Pharmaceuticals' KB001-A Fails Primary Endpoint - Analyst Blog

The Biggest Risks For Stocks In 2015?

Progenics (PGNX) Shares March Higher, Can It Continue? - Tale of the Tape

Progenics (PGNX) Shares March Higher, Can It Continue? - Tale of the Tape

Tiger Management's Julian Robertson Buys Alibaba, eBay, MasTec, Sells Tableau Software, ...

Progenics Pharmaceutical (PGNX) Upgraded From Sell to Hold

Ex-Boxer Paul Tudor Jones Delivering Knockout Punches on Wall Street

Ex-Boxer Paul Tudor Jones Delivering Knockout Punches on Wall Street

Progenics Pharmaceuticals' (PGNX) CEO Mark Baker Q3 2014 Results - Earnings Call Transcript

See More PGNX News...

PGNX's Top Competitors

PGNX $6.10 (0.66%)
Current stock: PGNX
AMGN $154.24 (-0.26%)
Current stock: AMGN
GILD $103.11 (0.64%)
Current stock: GILD
BIIB $347.07 (-1.17%)
Current stock: BIIB